17P Direct inhibition of RAS reveals the features of oncogenic signaling driven by RAS G12 and Q61 mutations. - Marasco, M.; Kumar, D.; Garcia Borrego, S.; Seale, T.; Maddalena, G.; Mezzadra, R.; Belanger, K.; Cole, S.; Perez, B.; Luan, W.; Arena, S.; Bardelli, A.; et al. (Annals of Oncology, 2025)